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Lozach and colleagues show that phleboviruses (bunyaviridae), which comprise important emerging viral
pathogens, exploit the C-type lectin DC-SIGN for dendritic cell binding, entry, and infection. The authors
elegantly visualize the cellular processes underlying DC-SIGN-dependent viral capture and uptake.Bunyaviruses pose a serious threat to
human health (Soldan and Gonza´lez-
Scarano, 2005). Members of the Hanta-
virus genus of the family bunyaviridae
are transmitted to humans via rodents
and cause hemorrhagic fever with renal
syndrome or hantavirus pulmonary syn-
drome, with case-fatality rates of up to
60%. Phleboviruses are arthropod-borne
bunyaviruses (arboviruses) and are trans-
ferred to humans when their arthropod
vectors,mainlymosquitoes and sandflies,
take a blood meal (Soldan and Gonza´lez-
Scarano, 2005). Infection with Rift Valley
fever virus (RVFV), a phlebovirus circu-
lating in Africa and Arabia, can induce
fatal hemorrhagic fever, and recent RVFV
outbreaks were associated with case-
fatality rates of up to 45%. At present,
neither vaccines nor therapeutics are
available against RVFV infection of hu-
mans. Changes in the natural distribution
and density of arthropod vectors can
allow the spread of known phleboviruses
to naı¨ve populations or may facilitate the
transmission of new phleboviruses to hu-
mans. Indeed, a previously unknownphle-
bovirus has recently been identified as the
causative agent of severe fever and
thrombocytopenia syndrome, a new dis-
ease documented in rural areas of central
China, which is associated with case-
fatality rates of approximately 30% (Yu
et al., 2011).
On the molecular level, Bunyaviruses
are enveloped viruses, harboring a tri-
partite, negative, or ambisense orientated
single-stranded RNA genome encoding
four structural proteins (Soldan and Gon-
za´lez-Scarano, 2005). The nucleocapsid
protein and the RNA-dependent RNA
polymerase are located inside the enve-
lope and are essential for genome replica-
tion and gene expression. The viral glyco-
proteins, Gn and Gc, are inserted into the
viral membrane and facilitate viral entryinto target cells. The glycoproteins are
synthesized as a single precursor protein,
which is cotranslationally processed by
host cell proteases into Gn and Gc. Both
proteins are N-glycosylated by host-cell
enzymes, and addition of N-glycans is
required for protein folding and viral infec-
tivity. Heterodimers of Gn and Gc are
incorporated into the viral envelope dur-
ing virus assembly in the Golgi apparatus.
The key task of viral glycoproteins is to
facilitate fusion of the viral membrane
with a host-cell membrane, thereby allow-
ing the subsequent release of viral pro-
teins and genomic information into the
host-cell lumen. To accomplish this task,
viral glycoproteins engage receptors on
the host-cell surface, with the term
receptor, for the purpose of this discus-
sion, being defined as a cellular molecule
engaged by a virus for infectious entry into
an otherwise nonsusceptible cell. Recep-
tor binding either triggers the glycopro-
teins for fusion with the plasma mem-
brane or facilitates viral uptake into
endosomal compartments where low pH
induces the glycoprotein-driven mem-
brane merger. Bunyaviruses infect cells
via the endosomal route (Lozach et al.,
2010). However, the cellular receptors
employed by Bunyaviruses for host-cell
entry have not been identified thus far,
and the paucity of information on virus-
host interactions during bunyavirus entry
limits therapeutic and preventive appro-
aches. Hantaviruses constitute an excep-
tion, since they are known to use beta-3
integrins for infection of endothelial cells.
The lectin DC-SIGN (CD209) is a type II
transmembraneproteinwith anN-terminal
cytoplasmic domain followed by a neck
domain and a C-terminal lectin domain.
The lectin domain facilitates binding to
mannose- and fucose-containing ligands
in a calcium-dependent (C-type) fashion.
High-avidity ligand-binding depends onCell Host & MicroDC-SIGN tetramerization, which is cata-
lyzed by the neck domain. Bound ligands
can be internalized due to specific se-
quences in the DC-SIGN cytoplasmic
domain, which trigger its endocytosis.
DC-SIGN was initially identified in pla-
cental tissue as an attachment factor for
the human immunodeficiency virus (HIV).
Subsequently, DC-SIGN was shown to
be expressed on monocyte-derived den-
dritic cells (MDDCs) and submucosal
dendritic cells (Geijtenbeek et al., 2000),
and evidence was provided that several
glycosylated pathogens, including vir-
uses, bacteria, and fungi, hijack dendritic
cell functions via DC-SIGN to promote
their dissemination (Tsegaye and Po¨hl-
mann, 2010).
Lozach and colleagues demonstrate
that phleboviruses recruit DC-SIGN for
infectious entry into dendritic cells (Loz-
ach et al., 2011), which may be among
the first cells exposed to viruses trans-
mitted by arthropod vectors. Employ-
ing sophisticatedmicroscopy techniques,
they spatially and temporally resolve virus
interactions with DC-SIGN during viral
attachment and uptake, thereby providing
valuable insights into DC-SIGN cellular
biology. Antibody and siRNA inhibition
studies showed that several phlebovi-
ruses, including Toscana virus (TOSV)
and RVFV as well as their nonpathogenic
relative Uukuniemi virus (UUKV), employ
DC-SIGN for attachment and infectious
entry into cell lines and MDDCs. Certain
cell lines remained nonsusceptible to
UUKV and TOSV infection in the absence
of DC-SIGN expression, despite expo-
sure to a high dose of virus, and were
rendered susceptible upon engineered
DC-SIGN expression. Thus, DC-SIGN ex-
pression is likely sufficient for phlebo-
virus entry, although a role for a co-
receptor cannot be completely excluded.
DC-SIGN binding was dependent on thebe 10, July 21, 2011 ª2011 Elsevier Inc. 5
Figure 1. Engagement of DC-SIGN by Phleboviruses for Infectious Entry into Dendritic Cells
Phleboviruses bind to DC-SIGN on dendritic cells via high-mannose glycans present on the viral glycopro-
teins. Virus binding induces rapid DC-SIGN clustering followed by DC-SIGN-dependent internalization of
bound virus into early endosomes. The low pH in early endosomes interferes with DC-SIGN tetramer
formation and induces release of virions fromDC-SIGN. Upon release of ligand, DC-SIGN is likely recycled
to the cell surface, while virions are trafficked into late endosomes/lysosomes. The increased acidification
of late compared to early endosomes triggers viral glycoprotein-driven fusion of the viral and the endoso-
mal membrane (optimal fusion occurs at pH 5.4). As a consequence, viral proteins and nucleic acids are
released into the host-cell cytoplasm, where they usurp the host-cell biosynthetic capacities for produc-
tion of progeny particles.
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mannose glycans. Insect cell-derived
glycans are exclusively of the high-
mannose type and phleboviruses gener-
ated in arthropods are therefore optimally
equipped to engage DC-SIGN. Glycosyl-
ation of phleboviruses in mammalian cells
was also compatible with DC-SIGN us-
age, indicating that amplification of arth-
ropod-derived virus in dendritic cells
may not compromise DC-SIGN usage. In
contrast, dengue virus, an arbovirus of
the flaviviridae family, which also engages
DC-SIGN for dendritic cell infection, loses
the ability to bind to DC-SIGN after ampli-
fication in dendritic cells, due to inade-
quate glycosylation (Dejnirattisai et al.,
2011). In sum, the results reported by Loz-
ach and colleagues suggest that phlebo-
viruses exploit DC-SIGN for infection of
dermal dendritic cells upon viral transmis-
sion by arthropod vectors (Figure 1). How-
ever, DC-SIGN-positive cells in the der-
mis were suggested to be mainly of
macrophage origin (Zaba et al., 2007),
and these cells appear to be markedly6 Cell Host & Microbe 10, July 21, 2011 ª201less permissive to dengue virus infection
than dendritic cells (Kwan et al., 2008).
Further studies would be required to ad-
dress the specific cell type(s) involved in
bunyavirus infection and the role of DC-
SIGN in vivo.
For DC-SIGN to function as a phlebovi-
rus receptor, the lectin should avidly bind
to virus and transport-bound virions into
acidic late-endosomal compartments,
the sites of glycoprotein-driven mem-
brane fusion (Lozach et al., 2010). Total
internal reflection fluorescence micros-
copy with live cells revealed that UUKV
recruited DC-SIGN into clusters at the cell
surface (Figure 1). These clusters were
formed within minutes at room tempera-
ture, indicating that exposure of dendritic
cells to phleboviruses induces rapid DC-
SIGN accumulation at sites of viral attach-
ment, which may be required for efficient
virus binding and internalization. The
vast majority of bound virions were inter-
nalized within 15 min and ultrastructural
analysis revealed that clathrin-coated
vesicles contributed to viral uptake. The1 Elsevier Inc.cytoplasmic tail of DC-SIGN contains
a di-leucine (LL) motif, which functions
as a signal for endocytosis (Engering
et al., 2002). Mutation of the LL motif did
not impact phlebovirus binding to DC-
SIGN but inhibited cellular uptake of virus
and markedly reduced infection effi-
ciency. Thus, DC-SIGN activity as a phle-
bovirus receptor critically depends on the
ability of the lectin to mediate viral uptake.
Confocal microscopy demonstrated that
DC-SIGN and phlebovirus particles had
parted ways in the early endosome at
20 min after uptake, probably due to pH-
dependent dissociation of DC-SIGN
tetramers. While DC-SIGN was likely re-
cycled to the cell surface, virions were
trafficked to late endosomes, where pH
below 5.8 triggers the membrane fusion
reaction (Lozach et al., 2010). Collectively,
DC-SIGN facilitates phlebovirus uptake
into target cells, where exposure to grad-
ually decreasing endosomal pH first
induces virus dissociation from DC-SIGN
and then triggers fusion of viral and endo-
somal membranes (Figure 1).
The finding that DC-SIGN is a receptor
for phlebovirus entry into dendritic cells
has implications for therapeutic and pre-
ventive approaches and poses interesting
new questions for future research. It is
tempting to speculate that DC-SIGN-
related lectins, like DC-SIGNR/L-SIGN
on liver and lymph-node sinusoidal endo-
thelial cells or mannose receptor (MR) on
macrophages and dendritic cells, could
capture phleboviruses and modulate viral
spread. Conversely, it remains to be ex-
amined if DC-SIGN contributes to den-
dritic cell infection by bunyaviruses out-
side the phlebovirus genus. In addition, it
should be investigated if phleboviruses
induce DC-SIGN-dependent signaling,
which alters dendritic cell maturation and
thus the establishment of an effective
antiviral immune response. Finally, DC-
SIGN is not the only receptor for phlebovi-
ruses, since these viruses infect are
variety of DC-SIGN-negative cells and tis-
sues, and the identification of the elusive
receptors remains an important goal.
REFERENCES
Dejnirattisai, W., Webb, A.I., Chan, V., Jumnain-
song, A., Davidson, A., Mongkolsapaya, J., and
Screaton, G. (2011). J. Infect. Dis. 203, 1775–1783.
Engering, A., Geijtenbeek, T.B., van Vliet, S.J.,
Wijers, M., van Liempt, E., Demaurex, N., Lanza-
vecchia, A., Fransen, J., Figdor, C.G., Piguet, V.,
Cell Host & Microbe
Previewsand van Kooyk, Y. (2002). J. Immunol. 168, 2118–
2126.
Geijtenbeek, T.B., Kwon, D.S., Torensma, R., van
Vliet, S.J., van Duijnhoven, G.C., Middel, J., Corne-
lissen, I.L., Nottet, H.S., KewalRamani, V.N.,
Littman, D.R., et al. (2000). Cell 100, 587–597.
Kwan, W.H., Navarro-Sanchez, E., Dumortier, H.,
Decossas, M., Vachon, H., dos Santos, F.B., Frid-
man, H.W., Rey, F.A., Harris, E., Despres, P., and
Mueller, C.G. (2008). PLoSNegl. Trop. Dis. 2, e311.Lozach, P.Y., Ku¨hbacher, A., Meier, R., Mancini,
R., Bitto, D., Bouloy, M., and Helenius, A. (2011).
Cell Host Microbe 10, this issue, 75–88.Lozach, P.Y., Mancini, R., Bitto, D., Meier, R., Oes-
tereich, L., Overby, A.K., Pettersson, R.F., and Hel-
enius, A. (2010). Cell Host Microbe 7, 488–499.Soldan, S.S., and Gonza´lez-Scarano, F. (2005). J.
Neurovirol. 11, 412–423.Cell Host & MicroTsegaye, T.S., and Po¨hlmann, S. (2010). Cell.
Microbiol. 12, 1553–1561.Yu, X.J., Liang, M.F., Zhang, S.Y., Liu, Y., Li, J.D.,
Sun, Y.L., Zhang, L., Zhang, Q.F., Popov, V.L., Li,
C., et al. (2011). N. Engl. J. Med. 364, 1523–1532.Zaba, L.C., Fuentes-Duculan, J., Steinman, R.M.,
Krueger, J.G., and Lowes, M.A. (2007). J. Clin.
Invest. 117, 2517–2525.be 10, July 21, 2011 ª2011 Elsevier Inc. 7
